Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Solid Tumor × alpha-Synuclein × Clear all

Phase

Phase EARLY_PHASE1 2

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Interventions

alpha-Synuclein 2 temsirolimus 1 Valproic Acid 1 Resistant Starch 1 Paclitaxel 1 Indocyanine Green 1 Cyclophosphamide 1 Carboxylesterase 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03815084 2019-01-30

A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors

Allife Medical Science and Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT03815630 2019-01-30

DC-CIK

Allife Medical Science and Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡